rs185620750
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BP4_Strong
The NM_001267550.2(TTN):c.67706G>A(p.Arg22569Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000074 in 1,607,914 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R22569W) has been classified as Likely benign.
Frequency
Consequence
NM_001267550.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTN | NM_001267550.2 | c.67706G>A | p.Arg22569Gln | missense_variant | 320/363 | ENST00000589042.5 | |
TTN-AS1 | NR_038272.1 | n.2044-3248C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTN | ENST00000589042.5 | c.67706G>A | p.Arg22569Gln | missense_variant | 320/363 | 5 | NM_001267550.2 | P1 | |
ENST00000603521.1 | n.535C>T | non_coding_transcript_exon_variant | 1/1 | ||||||
TTN-AS1 | ENST00000659121.1 | n.417-18272C>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? AF: 0.000283 AC: 43AN: 152010Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000163 AC: 40AN: 246004Hom.: 0 AF XY: 0.000142 AC XY: 19AN XY: 133534
GnomAD4 exome AF: 0.0000522 AC: 76AN: 1455786Hom.: 0 Cov.: 33 AF XY: 0.0000608 AC XY: 44AN XY: 723470
GnomAD4 genome ? AF: 0.000283 AC: 43AN: 152128Hom.: 1 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74380
ClinVar
Submissions by phenotype
not provided Uncertain:3Other:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Sep 13, 2022 | - - |
not provided, no classification provided | clinical testing | GeneDx | Jun 23, 2014 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 13, 2017 | - - |
Uncertain significance, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Dec 07, 2016 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 06, 2015 | The p.Arg20001Gln variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 6/11478 Latino chromosomes by t he Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1 85620750). Computational prediction tools and conservation analysis do not provi de strong support for or against an impact to the protein. In summary, the clini cal significance of the p.Arg20001Gln variant is uncertain. - |
TTN-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 11, 2023 | The TTN c.67706G>A variant is predicted to result in the amino acid substitution p.Arg22569Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.096% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-179444051-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Oct 24, 2017 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at